Principal Investigator/Program Director (Last, first, middle): Mestecky, Jiri DESCRIPTION: State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project. Describe concisely the research design and methods for achieving these goals. Avoid summaries of past accomplishments and the use oi the first person. This description is meant to serve as a succinct and accurate description of the proposed work when separated from the application. If the application is funded, this description, s is, will become public information. Therefore, do not include proprietarvlconfidentialinformation. DONOT EXCEEDTHE SP,ACE PROVIDED. Periodontal disease (PD) shares many common features with other human chronic inflammatory disease, such as rheumatoid arthritis, including production of autoantibodies, infiltration of lesions with plasma cells producing mainly IgG, and aberrant glycosylation of IgG-linked glycans. Particularly striking is the deficiency of galactose (Gal) in N-linked glycan side-chains on IgG molecules. Glycans have a profound effect on the biological activities of immunoglobulins (Ig). Deficiency of Gal residues renders such molecules pathogenic due to the fact that terminal N-acetylglucosamine residues, normally covered by Gal, became exposed and are recognized by the ubiquitous mannose-binding lectin resulting in the activation of complement with all the inflammatory consequences resulting in tissue damage. 13ased on considerable literature reports and our preliminary data, we propose to test the hypothesis that Ig-producing cells found in abundance in mononuclear cell infiltrates in PD secrete Ig molecules with aberrant slycosylation pattern of their glycan moieties. This in turn alters the biological properties of such Ig molecules with respect to their ability to activate complement and to interact with Fc receptors expressed on phagoclrtic cells resident in the inflamed lesions. Reduced glycosylation of Ig is likely to be due to the effect of cytokines locally produced by several cell types found in inflammatory lesions. Therefore, we propose the following specific aims: 1) Characterize the pattern of glycosylation aberrancies of Ig molecules in PD patients by reactivities with lectins highly specific for component monosaccharides and by direct carbohydrate analyses. 2) Determine the origin of aberrantly glycosylated Ig molecules by comparing glycosylation patterns of Ig in serum and lesions to determine whether Ig molecules with altered glycosylation are produced locally in the inflammatory lesions. 3) Determine if the aberrantly glycosylated Igs are specific for antigens of selected bacteria associated with PD. 4) Study mechanisms possibly involved in synthesis of Gal-deficient Ig.in PD patients and the biological activities of Ig molecules with altered glycans. Results of these studies will generate information concerning previously unexplored inflammatory pathways that participate in the development of PI). 'ERFORMANCESITE@) (organization,city, state) University of Alabama at Birmingham, Schools of Medicine and Dentistry, Birmingham, AL Columbia University, School of Dental and Oral Surgery, New York, NY KEY PERSONNEL ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE013694-04
Application #
6910708
Study Section
Special Emphasis Panel (ZRG1-OBM-1 (01))
Program Officer
Lumelsky, Nadya L
Project Start
2002-09-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$298,950
Indirect Cost
Name
University of Alabama Birmingham
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Komiyama, Yuske; Kafkova, Leona Raskova; Barasch, Andrei et al. (2014) Origin of galactose-deficient immunoglobulin g in gingival crevicular fluid in periodontitis. J Periodontol 85:1779-85
Gomes, Michelle M; Wall, Stephanie B; Takahashi, Kazuo et al. (2008) Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding. Biochemistry 47:11285-99
Moore, Jennifer S; Kulhavy, Rose; Tomana, Milan et al. (2007) Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 44:2598-604
Raska, Milan; Moldoveanu, Zina; Suzuki, Hitoshi et al. (2007) Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells. J Mol Biol 369:69-78
Renfrow, Matthew B; Mackay, C Logan; Chalmers, Michael J et al. (2007) Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal Bioanal Chem 389:1397-407
Zurbig, Petra; Renfrow, Matthew B; Schiffer, Eric et al. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27:2111-25
Novak, J; Tomana, M; Shah, G R et al. (2005) Heterogeneity of IgG glycosylation in adult periodontal disease. J Dent Res 84:897-901
Moore, Jennifer S; Wu, Xueling; Kulhavy, Rose et al. (2005) Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS 19:381-9
Renfrow, Matthew B; Cooper, Helen J; Tomana, Milan et al. (2005) Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 280:19136-45